MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
Claim Your Discount
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?

Laboratory Co. of America - LH Stock Forecast, Price & News

-4.76 (-2.21%)
(As of 10/6/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
604,088 shs
Average Volume
614,369 shs
Market Capitalization
$19.49 billion
P/E Ratio
Dividend Yield
Price Target

Laboratory Co. of America MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.57 Rating Score
42.6% Upside
$299.75 Price Target
Short Interest
2.04% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
1.01mentions of Laboratory Co. of America in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$14.08 M Sold Last Quarter
Proj. Earnings Growth
From $20.26 to $18.08 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.81 out of 5 stars

Medical Sector

49th out of 1,075 stocks

Medical Laboratories Industry

1st out of 29 stocks

LH stock logo

About Laboratory Co. of America (NYSE:LH) Stock

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.

LH Stock News Headlines

Laboratory Corp: The Force Is Strong With This One
See More Headlines
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.

LH Company Calendar

Last Earnings
Ex-Dividend for 9/9 Dividend
Dividend Payable
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Medical laboratories
Health Care Services
Year Founded

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
$2.38 billion
Pretax Margin


Sales & Book Value

Annual Sales
$16.12 billion
Cash Flow
$36.01 per share
Book Value
$107.35 per share


Free Float
Market Cap
$19.49 billion

Social Links

Key Executives

  • Mr. Adam H. Schechter (Age 57)
    Pres, CEO & Chairman
    Comp: $5.51M
  • Mr. Glenn A. EisenbergMr. Glenn A. Eisenberg (Age 61)
    CFO & Exec. VP
    Comp: $2.3M
  • Dr. Brian J. Caveney M.P.H. (Age 48)
    M.D., J.D., MPH, Exec. VP, Pres of Diagnostics & Chief Medical Officer
    Comp: $1.57M
  • Mr. Mark S. Schroeder (Age 61)
    Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain
    Comp: $1.59M
  • Dr. Paul R. Kirchgraber M.D.Dr. Paul R. Kirchgraber M.D. (Age 60)
    Exec. VP & CEO of Covance Drug Devel.
    Comp: $2.02M
  • Dr. Michelle Abelson Ph.D.
    Laboratory Director of Operations
  • Mr. Peter J. WilkinsonMr. Peter J. Wilkinson (Age 50)
    Sr. VP & Chief Accounting Officer
  • Mr. Lance V. Berberian (Age 59)
    Exec. VP and Chief Information & Technology Officer
  • Dr. Marcia T. Eisenberg Ph.D. (Age 62)
    Chief Scientific Officer & Sr. VP
  • Chas Cook
    VP of Investor Relations

LH Stock - Frequently Asked Questions

Should I buy or sell Laboratory Co. of America stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LH shares.
View LH analyst ratings
or view top-rated stocks.

What is Laboratory Co. of America's stock price forecast for 2022?

7 Wall Street research analysts have issued 12-month price targets for Laboratory Co. of America's shares. Their LH share price forecasts range from $235.00 to $350.00. On average, they predict the company's stock price to reach $299.75 in the next year. This suggests a possible upside of 42.6% from the stock's current price.
View analysts price targets for LH
or view top-rated stocks among Wall Street analysts.

How have LH shares performed in 2022?

Laboratory Co. of America's stock was trading at $314.21 at the beginning of 2022. Since then, LH stock has decreased by 33.1% and is now trading at $210.27.
View the best growth stocks for 2022 here

Are investors shorting Laboratory Co. of America?

Laboratory Co. of America saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,840,000 shares, an increase of 18.7% from the August 31st total of 1,550,000 shares. Based on an average daily volume of 577,800 shares, the short-interest ratio is currently 3.2 days. Approximately 2.0% of the company's stock are short sold.
View Laboratory Co. of America's Short Interest

When is Laboratory Co. of America's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our LH earnings forecast

How can I listen to Laboratory Co. of America's earnings call?

Laboratory Co. of America will be holding an earnings conference call on Thursday, October 27th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) posted its quarterly earnings results on Thursday, July, 28th. The medical research company reported $4.96 earnings per share for the quarter, beating analysts' consensus estimates of $4.67 by $0.29. The medical research company earned $3.70 billion during the quarter, compared to analysts' expectations of $3.76 billion. Laboratory Co. of America had a trailing twelve-month return on equity of 22.39% and a net margin of 12.67%. The company's revenue for the quarter was down 3.7% compared to the same quarter last year. During the same period last year, the firm earned $6.13 EPS.
Read the conference call transcript

How often does Laboratory Co. of America pay dividends? What is the dividend yield for Laboratory Co. of America?

Laboratory Co. of America announced a quarterly dividend on Thursday, July 14th. Investors of record on Thursday, August 18th will be given a dividend of $0.72 per share on Friday, September 9th. This represents a $2.88 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend is Wednesday, August 17th.
Read our dividend analysis for LH

Is Laboratory Co. of America a good dividend stock?

Laboratory Co. of America (NYSE:LH) pays an annual dividend of $2.88 per share and currently has a dividend yield of 1.34%. The dividend payout ratio is 13.78%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LH will have a dividend payout ratio of 15.93% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LH.

What guidance has Laboratory Co. of America issued on next quarter's earnings?

Laboratory Co. of America updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $19.00-$21.25 for the period, compared to the consensus earnings per share estimate of $19.70. The company issued revenue guidance of $15.15 billion-$15.80 billion, compared to the consensus revenue estimate of $15.31 billion.

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America Chief Executive Officer Adam Schechter on Adam Schechter has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include American National Bank (0.03%) and Csenge Advisory Group (0.00%). Insiders that own company stock include Amy B Summy, Brian J Caveney, David P King, Der Vaart Sandra D Van, Der Vaart Sandra D Van, Dwight Gary Gilliland, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Mark S Schroeder, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, Peter M Neupert and R Sanders Williams.
View institutional ownership trends

How do I buy shares of Laboratory Co. of America?

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $210.27.

How much money does Laboratory Co. of America make?

Laboratory Co. of America (NYSE:LH) has a market capitalization of $19.49 billion and generates $16.12 billion in revenue each year. The medical research company earns $2.38 billion in net income (profit) each year or $20.90 on an earnings per share basis.

How many employees does Laboratory Co. of America have?

The company employs 75,500 workers across the globe.

Does Laboratory Co. of America have any subsidiaries?
The following companies are subsidiares of Laboratory Co. of America: 1957285 Ontario Inc. dba Quality Underwriting Services, 2089729 Ontario Inc., 2248848 Ontario Inc., 3065619 Nova Scotia Company, 3257959 Nova Scotia Company, 8165335 Canada Inc., 8348596 Canada Inc., 896988 Ontario Limited, 9279-3280 Quebec Inc., Accupath Diagnostic Laboratories Inc., Assets of Pathology Inc, Beacon LBS IPA Inc., Beacon Laboratory Benefit Solutions Inc., CannAmm GP Inc., CannAmm Limited Partnership, Center for Disease Detection International, Center for Disease Detection LLC, Centrex Clinical Laboratories Inc., Chiltern, Clearstone Central Laboratories (U.S.) Inc., Clearstone Holdings (International) Ltd., Clinical Outreach Laboratory Services, Clipper Holdings Inc., Colorado Coagulation Consultants Inc., Colorado Laboratory Services LLC, Correlagen Diagnostics Inc., Covance Inc., Curalab Inc., Cytometry Associates Inc., Czura Thornton (Hong Kong) Limited, DCL Acquisition Inc., DCL Medical Laboratories LLC, DCL Sub LLC, DIANON Systems Inc., DL Holdings Limited Partnership, Decision Diagnostics L.L.C. (aka DaVinici/Medicorp LLC), Diagnostic Services Inc., DynaLifeDX, Dynacare - Gamma Laboratory Partnership, Dynacare Company, Dynacare G.P. Inc., Dynacare Holdco LLC, Dynacare Laboratories Inc., Dynacare Laboratories Limited Partnership, Dynacare Northwest Inc., Dynacare Realty Inc., DynalifeDX Infrastructure Inc., Envigo's nonclinical contract research services business, Esoterix Genetic Counseling LLC, Esoterix Genetic Laboratories LLC, Esoterix Inc., Execmed Health Services Inc., FirstSource Laboratory Solutions Inc., GDML Medical Laboratories Inc, Gamma Dynacare Central Medical Laboratories GP Inc., Gamma Dynacare Central Medical Laboratory Limited Partnership, HHLA Lab-In-An-Envelope LLC, Health Testing Centers Inc., Health Trans Services Inc., Home Healthcare Laboratory of America LLC, IDX Pathology Inc., Impact Genetics Corporation, Impact Genetics Inc., Kaleida LabCorp LLC, Lab Delivery Service of New York City Inc., LabCorp BVBA, LabCorp Belgium Holdings Inc., LabCorp Central Laboratories (Canada) Inc., LabCorp Central Laboratories (China) Inc., LabCorp Colorado Inc., LabCorp Development Company, LabCorp Employer Services Inc., LabCorp Health System Diagnostics LLC, LabCorp Indiana Inc., LabCorp Japan G.K., LabCorp Limited, LabCorp Michigan Inc., LabCorp Nebraska Inc., LabCorp Neon Ltd., LabCorp Neon Switzerland S.à.r.l., LabCorp Specialty Testing Billing Service Inc., LabCorp Specialty Testing Group Inc., LabCorp Staffing Solutions Inc., LabCorp Tennessee LLC, LabCorp UK Holdings Ltd., LabWest Inc., Laboratoire Bio-Medic Inc., Laboratory Corporation of America, Lifecodes Corporation, LipoScience Inc., Litholink Corporation, MEDTOX Scientific Inc., MNG Laboratories, MedAxio Insurance Medical Services GP Inc., MedAxio Insurance Medical Services LP, Medical Neurogenitics LLC, Medtox Diagnostics Inc., Medtox Laboratories Inc., Monogram Biosciences Inc., Monogram Biosciences UK Limited, Myriad Autoimmune’s Vectra Testing Business, NWT Inc., National Genetics Institute, New Brighton Business Center LLC, New Imaging Diagnostics LLC, New Molecular Diagnostics Ventures LLC, Orchid Cellmark ULC, Ovia Health, PA Labs Inc., Paclab LLC, Path Lab Incorporated, Pathology Associates Medical Lab LLC, Pee Dee Pathology Associates Inc., Personal Genome Diagnostics Inc., Persys Technology Inc., Pixel by LabCorp, Princeton Diagnostic Laboratories of America Inc., Protedyne Corporation, SW/DL LLC, Saint Josephs-PAML LLC, Sequenom Biosciences (India) Pvt. Ltd., Sequenom Inc, Sequenom Inc., Tandem Labs Inc., Toxikon Corporation, Tri-Cities Laboratory LLC, Viro-Med Laboratories Inc., Visiun, and Yakima Medical Arts Inc..
Read More
How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The official website for the company is The medical research company can be reached via phone at (336) 229-1127, via email at, or via fax at 336-513-4510.

This page (NYSE:LH) was last updated on 10/7/2022 by Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.